Delivery Order SPE2DB24D2216-SPE2DB25FGPBG

Award Date 6/24/25
Potential Completion Date 6/25/25
Potential Value $44K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML. The contract has a ceiling value of $6,380.61 and a period of performance ending on May 28, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a pharmaceutical product, with a ceiling value of $2,601.43 and a period of performance through June 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a pharmaceutical product, with a ceiling value of $7,573.96 and a period of performance through May 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML, a pharmaceutical product, with a ceiling value of $24,393.48. The contract is a firm fixed-price delivery order, with a performance period through May 29, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of medical products including the drug FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML. The contract has a ceiling value of $32,141.18 and is a firm fixed price arrangement with a performance period ending on June 13, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,833.32, is for the delivery of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a specialty pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML. The contract has a ceiling value of $28,249.23 and a period of performance through January 31, 2025. The contract is a firm fixed price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML. The contract has a ceiling value of $5,897.47 and a period of performance through June 9, 2025. It is a firm fixed-price contract, indicating a set price for the medications. The contract is not designated as a set-aside, meaning it was open to full and open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML. The contract has a ceiling value of $3,170.25 and a completion date of January 23, 2024. It is a firm fixed-price contract type. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML. The contract has a ceiling value of $3,482.73 and an ultimate completion date of March 13, 2024. This delivery order is placed under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA,...
  • SPE2DB24D2216
    Indefinite Delivery Contract
  • SPE2DB24D2216-SPE2DB25FGPBG
    Delivery Order

This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FORTEO 560 MCG/2.24 ML PEN INJ 2.24ML. The contract has a ceiling value of $43,978.23 and a period of performance through June 25, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military and other government healthcare programs through December 2026.

Generated 9/28/25, 2:04 AM